Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Treasury Shares: 2022-2023

Historic Treasury Shares for Sunshine Biopharma (SBFM) over the last 1 years, with Dec 2023 value amounting to $257.

  • Sunshine Biopharma's Treasury Shares was N/A to $257 in Q4 2023 from the same period last year, while for Dec 2023 it was $257, marking a year-over-year change of. This contributed to the annual value of $257 for FY2023, which is N/A change from last year.
  • Per Sunshine Biopharma's latest filing, its Treasury Shares stood at $257 for Q4 2023, which was down 0.00% from $257 recorded in Q3 2023.
  • In the past 5 years, Sunshine Biopharma's Treasury Shares ranged from a high of $990,000 in Q2 2022 and a low of -$990,000 during Q3 2022.
  • For the 2-year period, Sunshine Biopharma's Treasury Shares averaged around $74,742, with its median value being $1,242 (2023).
  • Examining YoY changes over the last 5 years, Sunshine Biopharma's Treasury Shares showed a top increase of 100.03% in 2023 and a maximum decrease of 99.77% in 2023.
  • Over the past 2 years, Sunshine Biopharma's Treasury Shares (Quarterly) stood at -$990,000 in 2022, then soared by 100.03% to $257 in 2023.
  • Its Treasury Shares was $257 in Q4 2023, compared to $257 in Q3 2023 and $2,228 in Q2 2023.